Chimera Investment (NYSE:CIM) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $13.00 price target on the stock.
Chimera Investment (NYSE:CIM) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Chimera Investment (NYSE:CIM) had its price target lowered by analysts at UBS Group AG from $16.00 to $15.50. They now have a "buy" rating on the stock.
Chimera Investment (CIM): Evaluating Valuation After Latest Share Price Decline [Yahoo! Finance]
Chimera Investment (NYSE:CIM) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.